| Income Statement |
| Total Revenue | 3.07B |
|
| Revenues (USD) | 452.19M |
| Cost of Revenue | 2.61B |
| Gross Profit | 466.21M |
| Operating Expenses | 425.69M |
| Research and Development Expense | 189.91M |
| Selling, General and Administrative Expense | 253.30M |
| Operating Income | 40.52M |
| Interest Expense | 166.77M |
| Income Tax Expense | 16.51M |
| Net Income | -93.08M |
| Net Income Common Stock | -93.08M |
| Net Income Common Stock (USD) | -13.70M |
| Consolidated Income | -92.98M |
| Net Income to Non-Controlling Interests | 101.00K |
| Earnings per Basic Share | -0.30 |
| Earnings per Basic Share (USD) | -0.04 |
| Earnings per Diluted Share | -0.30 |
| Earning Before Interest & Taxes (EBIT) | 90.20M |
| Earning Before Interest & Taxes (USD) | 13.28M |
| Weighted Average Shares | 4.56B |
| Weighted Average Shares Diluted | 4.56B |
| Balance Sheet |
| Cash and Equivalents | 4.73B |
| Cash and Equivalents (USD) | 696.14M |
| Investments | 336.50M |
| Investments Non-Current | 336.50M |
| Trade and Non-Trade Receivables | 3.14B |
| Current Assets | 10.98B |
| Property, Plant & Equipment Net | 13.92B |
| Total Assets | 30.70B |
| Debt Current | 3.35B |
| Total Debt | 6.86B |
| Current Liabilities | 10.86B |
| Debt Non-Current | 3.51B |
| Total Liabilities | 21.81B |
| Accumulated Retained Earnings (Deficit) | -15.68B |
| Accumulated Other Comprehensive Income | 336.80M |
| Shareholders Equity | 8.90B |
| Shareholders Equity (USD) | 1.31B |
| Assets Non-Current | 19.72B |
| Total Debt (USD) | 1.01B |
| Goodwill and Intangible Assets | 5.05B |
| Liabilities Non-Current | 10.95B |
| Trade and Non-Trade Payables | 2.43B |
| Tax Liabilities | 129.02M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 1.00B |
| Net Cash Flow from Financing | -109.64M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -221.40M |
| Net Cash Flow from Investing | -2.91B |
| Net Cash Flow from Operations | 2.85B |
| Effect of Exchange Rate Changes on Cash | -49.82M |
| Share Based Compensation | 57.26M |